DAVID ONEAL: Open Payments
NPI 1952918625 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,796 in 92 payments from 18 companies in 2025. Trend: 2023 $2,096 · 2024 $1,521 · 2025 $1,796
Food & beverage: $1,796
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $333 |
| AstraZeneca Pharmaceuticals LP | 15 | $302 |
| GENZYME CORPORATION | 9 | $233 |
| Amgen Inc. | 8 | $139 |
| Merck Sharp & Dohme LLC | 5 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
| Viatris Specialty LLC | 4 | $83 |
| Verona Pharma, Inc. | 4 | $76 |
Products named: DUPIXENT, TRELEGY ELLIPTA, AIRSUPRA, TEZSPIRE, WINREVAIR, GLASSIA, OFEV, FASENRA.
Industry payments across TX — which companies pay providers there.
